Quantcast
Last updated on April 18, 2014 at 7:49 EDT

Latest Rosuvastatin Stories

2010-10-28 03:48:00

NEW YORK, Oct. 28 /PRNewswire/ -- See video from AstraZeneca at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=7c13a65b-0529-4b28-82e0-7ebe8b9d9f42&bhcp=1&alertid=226c94c1-b49b-45a9-b982-615158357500# Anglo-Swedish pharmaceutical company AstraZeneca announced that revenue for the third quarter declined by 2% at constant exchange rates (CER) to $7,898 million. Strong double-digit sales growth at CER for Crestor, Symbicort and Seroquel XR. Revenue in markets outside...

2010-10-27 07:00:00

MORRISTOWN, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed a new drug application under Section 505(b)(2) of the Federal Food and Drug Cosmetic Act (FFDCA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rosuvastatin zinc 5, 10, 20 and 40 mg tablets. Watson's rosuvastatin zinc tablets are a new salt version of AstraZeneca's Crestor ®...

2010-09-28 20:58:08

Average C-reactive protein (CRP) values vary in diverse populations "” possibly impacting how doctors estimate cardiovascular risk and determine statin treatment, according to a new study in Circulation: Cardiovascular Genetics, a journal of the American Heart Association. CRP is a marker of inflammation, and high levels of it in the blood have been associated with a higher risk for heart disease. But it's uncertain if the association is causal. Statins are a class of...

2010-09-07 07:00:00

WILMINGTON, Del., Sept. 7 /PRNewswire/ -- AstraZeneca (NYSE: AZN) urges Americans to take important steps to manage their cholesterol during National Cholesterol Education Month in September. Based on current estimates, 102 million Americans aged 20 years or older have borderline high or high cholesterol.(i) Adopting a healthy lifestyle, including a low-fat diet and exercise, along with cholesterol medication if needed, can help lower levels of LDL or "bad" cholesterol.(ii,, iii, iv) To...

2010-08-24 15:00:00

Study highlights: -- People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein (hsCRP), a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels. -- Data indicates that people with only a 5 percent to 20 percent risk of having heart disease in the next ten years, but who have high levels of hsCRP could reduce the risk of heart attack and stroke by more...

2010-07-29 07:22:00

FLORHAM PARK, N.J., July 29 /PRNewswire/ -- Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA(TM) (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA(TM) was designated an Orphan Drug by the FDA. "The FDA approval of CUVPOSA provides parents and caregivers the first liquid...

2010-07-26 13:04:28

The European Society of Cardiology (ESC) is concerned that interpretations of a paper about cholesterol, published in the Lancet (1), could act to deter ongoing research efforts into developing new therapeutic strategies to increase high density lipoprotein (HDL) cholesterol.  Caution, the ESC experts advise, should be displayed in the interpretation of the results. In the Lancet study, Paul Ridker and colleagues, from Brigham and Women's Hospital (Boston, MA, USA), undertook a...

2010-06-29 18:06:00

WILMINGTON, Del., June 29 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 - the '314 patent) is valid and enforceable. In its ruling, the court found that no inequitable conduct was committed by any Shionogi employee. The court also held the '314 patent to be non-obvious and properly reissued. (Logo:...

d1b7f19a553a506e973e96fa47fdc01f1
2010-06-29 11:00:00

On Monday, researchers said they did not find evidence that cholesterol-reducing drugs can help extend the life of patients at risk of heart disease. The study involved 65,229 people who were questioned about the use of the cholesterol-reducing drugs, also known as statins.  Statins are the world's top-selling prescription drugs.  According to health industry data firm IMC Health, over 238 million prescriptions for cholesterol-lowering drugs were dispensed by retail pharmacies in...

2010-06-29 05:00:00

Analyzes the Effectiveness and Safety of Statin Use for Those Who Need It Recommendations for Choosing a 'Best Buy' Statin and Strategies for Money-Saving YONKERS, N.Y., June 29 /PRNewswire-USNewswire/ -- A series of new reports from Consumer Reports Best Buy Drugs (BBD) caution that the benefits of statin use by children and some women may not outweigh the risks. Drugs to lower cholesterol -- including statins -- are the most commonly prescribed drugs in the U.S. and garnered more than...